Abbe Friedberg
Adult Health · New York, NYNPI 1700910312
Payments from drug & device makers
Across 402 payments — averaging $23.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$3K
- Gilead$3K
- Johnson & Johnson$701
- Merck$632
- AbbVie$602
- Shionogi Inc$170
- plus $1K from 24 others
What the payments were for
- Food & beverage$9,23998%
- Education$1602%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 157 | $3,450 |
| Gilead | 107 | $2,522 |
| Johnson & Johnson | 23 | $701 |
| Merck | 24 | $632 |
| AbbVie | 34 | $602 |
| Shionogi Inc | 6 | $170 |
| Janssen Products, LP | 3 | $160 |
| Hologic Sales And Service, LLC | 5 | $158 |
| Sanofi-aventis U.S. LLC | 5 | $100 |
| Axsome Therapeutics, Inc. | 4 | $96 |
| Theratechnologies Inc. | 3 | $87 |
| Pfizer | 3 | $76 |
| Bavarian Nordic A/s | 1 | $66 |
| Novo Nordisk | 3 | $58 |
| EMD Serono, Inc. | 3 | $57 |
| Daiichi Sankyo Inc. | 2 | $51 |
| Napo Pharmaceuticals Inc | 2 | $47 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Shield Therapeutics Inc | 2 | $37 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Exact Sciences | 1 | $31 |
| Philips North America LLC | 1 | $28 |
| Bausch Health US, LLC | 1 | $24 |
| GSK | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
| Antares Pharma, Inc. | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
How this compares
$9,399 in reported general payments places this provider in the 95th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 130 | $541,990 |
| DescovyEmtricitabine/Tenofov Alafenam | 70 | $158,812 |
| JulucaDolutegravir/Rilpivirine | 43 | $157,311 |
| TivicayDolutegravir Sodium | 64 | $142,748 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 37 | $140,149 |
| DovatoDolutegravir Sodium/Lamivudine | 25 | $70,848 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 15 | $57,966 |
| IsentressRaltegravir Potassium | 21 | $51,906 |
| PrezcobixDarunavir/Cobicistat | 14 | $38,246 |
| PifeltroDoravirine | 20 | $34,098 |
| IntelenceEtravirine | 17 | $29,049 |
| PrezistaDarunavir | 13 | $25,934 |
| EdurantRilpivirine Hcl | 18 | $25,200 |
| OzempicSemaglutide | 26 | $21,205 |
| Maraviroc | 19 | $19,143 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy, Genvoya | $2,522 | $758,768215 claims |
| Viiv Healthcare CompanyJuluca, Tivicay, Triumeq, Dovato | $3,450 | $511,057169 claims |
| MerckIsentress, Pifeltro | $632 | $86,00341 claims |
| Johnson & JohnsonPrezcobix | $701 | $38,24614 claims |
| Novo NordiskOzempic | $58 | $21,20526 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,828 adult health providers in New York.
Other adult health in New York
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Alyson HartyNew York$65K
- Laura GraaflandNew York$51K
- Allysa SaggeseNew York$49K
- Juliet EscalonNew York$46K
- Teshmanie RampersaudNew York$23K
- Jenna WenzelNew York$22K
- Elizabeth SavageNew York$20K
- Libby LevineNew York$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.